A new study reveals that antimicrobial resistance is rising worldwide - eroding the effectiveness of last-line antibiotics ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
Stocktwits on MSN
Omeros stock garners high retail attention ahead of FDA verdict for life-saving drug
Omeros said it had resubmitted its FDA application for Narsoplimab in March 2025, with the PDUFA target date later extended ...
Gudeta, B. (2025) Comparative Study of Rhodanese Specific Activity Assay Techniques for Plants and Bacterial Species.
Few medicines have sparked as much debate as statins. Cardiologists often describe them as life-saving, while some patients ...
Neurodegenerative disorders are pressing global health challenges that stem from progressive neuronal dysfunction and loss. While the central roles of ...
The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types of ...
FOR IMMEDIATE RELEASEGlucoModicum unveils Sofio™, the world’s first needle-free glucose monitor based on magneto-hydrodynamics ...
Below, Pasquariello breaks down some of the benefits you can realistically expect from a supplement like Daily Dose, her ...
Enzymes are essentially biological catalysts. They are proteins that speed up chemical reactions in the body that would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback